Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China.
Chin Med J (Engl). 2024 Aug 20;137(16):1926-1938. doi: 10.1097/CM9.0000000000002884. Epub 2024 Jan 16.
In East Asia, Helicobacter pylori ( H. pylori ) infection and related diseases are common, primarily during childhood and adolescence. The rates of primary antibiotic resistance in H. pylori among East Asian children and adolescents have not been extensively explored; few relevant systematic reviews or meta-analyses have been conducted. We evaluated the rates of antibiotic resistance in H. pylori among East Asian children and adolescents, with the goal of facilitating individualized treatment recommendations.
We searched PubMed, Embase, and the Cochrane Library for studies in any language published up to February 2023 that explored antibiotic resistance in H. pylori among East Asian children and adolescents. We used MeSH and non-MeSH terms related to the topic, including terms related to children, adolescents, antibiotic resistance, H. pylori , and nations or regions. Additionally, we reviewed the reference lists of relevant articles. Studies that matched our strict predefined eligibility criteria were included in the screening process. Using established assessment methods, we evaluated the quality of the included studies.
We identified 15 observational studies involving 4831 H. pylori isolates, all published between 2001 and 2022. There was substantial primary antibiotic resistance in H. pylori isolates from East Asian children and adolescents. The rates of primary resistance were 51% (95% confidence interval [CI]: 40-62%) for metronidazole; 37% (95% CI: 20-53%) for clarithromycin; 19% (95% CI: 11-28%) for levofloxacin; and less than 3% each for amoxicillin, tetracycline, and furazolidone. Subgroup analysis revealed a prominent increase in metronidazole resistance over time. Clarithromycin and levofloxacin resistance rates fluctuated between 2005 and 2015, then remained stable; other antibiotic resistance rates were generally stable. Metronidazole, clarithromycin, and levofloxacin resistance rates were significantly higher in the Chinese mainland than in other East Asian regions. The rates of dual and multiple antibiotic resistance were 28% (95% CI: 21-36%) and 10% (95% CI: 7-14%), highlighting the potential for diverse resistance patterns.
H. pylori isolates from East Asian children and adolescents exhibit high levels of metronidazole and clarithromycin resistance, particularly in the Chinese mainland. The non-negligible rates of dual and multiple resistance highlight the complexity of this problem.
PROSPERO, No. CRD42023402510.
在东亚,幽门螺杆菌(H. pylori)感染及相关疾病较为常见,主要发生于儿童和青少年时期。东亚儿童和青少年中 H. pylori 对抗生素的原发性耐药率尚未得到广泛研究,也很少有相关的系统评价或荟萃分析。本研究旨在为个体化治疗建议提供参考,评估了东亚儿童和青少年中 H. pylori 的抗生素耐药率。
我们检索了PubMed、Embase 和 Cochrane 图书馆中截至 2023 年 2 月以任何语言发表的研究,以探讨东亚儿童和青少年中 H. pylori 的抗生素耐药性。我们使用了与主题相关的 MeSH 和非 MeSH 术语,包括与儿童、青少年、抗生素耐药性、H. pylori 和国家或地区相关的术语。此外,我们还查阅了相关文章的参考文献列表。只有符合我们严格预设的纳入标准的研究才会被纳入筛选过程。我们使用既定的评估方法对纳入研究的质量进行了评估。
我们共纳入了 15 项观察性研究,共涉及 4831 株 H. pylori 分离株,均发表于 2001 年至 2022 年期间。东亚儿童和青少年的 H. pylori 分离株中存在较高水平的原发性抗生素耐药性。主要耐药率为:甲硝唑耐药率 51%(95%CI:40-62%);克拉霉素耐药率 37%(95%CI:20-53%);左氧氟沙星耐药率 19%(95%CI:11-28%);阿莫西林、四环素和呋喃唑酮的耐药率均小于 3%。亚组分析显示,甲硝唑耐药率呈显著上升趋势。克拉霉素和左氧氟沙星耐药率在 2005 年至 2015 年期间波动,随后趋于稳定;其他抗生素耐药率总体保持稳定。中国大陆地区的甲硝唑、克拉霉素和左氧氟沙星耐药率显著高于其他东亚地区。双重和多重抗生素耐药率分别为 28%(95%CI:21-36%)和 10%(95%CI:7-14%),提示存在多种耐药模式的可能性。
东亚儿童和青少年的 H. pylori 分离株对甲硝唑和克拉霉素的耐药率较高,尤其是在中国大陆地区。双重和多重耐药率不容忽视,突显了这一问题的复杂性。
PROSPERO,编号:CRD42023402510。